title: National Heart, Lung, and Blood Institute Workshop: improving outcomes for pulmonary vascular disease.
authors.affiliation: Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.
authors.forename: Ivan M
authors.initials: IM
authors.lastname: Robbins
authors.forename: Timothy M
authors.initials: TM
authors.lastname: Moore
authors.forename: Carol J
authors.initials: CJ
authors.lastname: Blaisdell
authors.forename: Steven H
authors.initials: SH
authors.lastname: Abman
mesh_terms: D000328:Adult; D000367:Age Factors; D015415:Biomarkers; D002317:Cardiovascular Agents / Q000627:therapeutic use; D002648:Child; D002986:Clinical Trials as Topic / Q000379:methods / Q000592:standards; D005544:Forecasting; D006801:Humans; D006976:Hypertension, Pulmonary / Q000145:classification / Q000209:etiology / Q000401:mortality / Q000503:physiopathology / Q000628:therapy*; D054555:National Heart, Lung, and Blood Institute (U.S.); D010641:Phenotype; D011379:Prognosis; D012106:Research; D014481:United States; D014655:Vascular Resistance
chemical_list: D015415:Biomarkers; D002317:Cardiovascular Agents